Skip to content
20-F/A

Annual Report (Foreign)

EMPOWER CLINICS INC.

0001654954-22-009809

← back to feed
Filed
Jul 19, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Jul 12, 2022 283.81M sh
Shares Diluted FY 2020 · Dec 31, 2020 182.33M sh
Shares Diluted FY 2020 · Dec 31, 2019 117.29M sh
Shares Diluted FY 2020 · Dec 31, 2018 66.67M sh
Operating Cash Flow FY 2020 · Dec 31, 2020 −$1.75M
Operating Cash Flow FY 2020 · Dec 31, 2019 −$2.27M
Operating Cash Flow FY 2020 · Dec 31, 2018 −$2.84M
Stockholders Equity FY 2020 · Dec 31, 2020 −$5.49M
Stockholders Equity FY 2020 · Dec 31, 2019 −$3.51M
Stockholders Equity FY 2020 · Dec 31, 2018 −$3M
Stockholders Equity restated FY 2020 · Dec 31, 2017 −$4.81M
Current Liabilities FY 2020 · Dec 31, 2020 $7M
Current Liabilities FY 2020 · Dec 31, 2019 $4.45M
Total Liabilities FY 2020 · Dec 31, 2020 $14.72M
Total Liabilities FY 2020 · Dec 31, 2019 $5.07M
Current Assets FY 2020 · Dec 31, 2020 $5.25M
Current Assets FY 2020 · Dec 31, 2019 $263.87K
Total Assets FY 2020 · Dec 31, 2020 $9.23M
Total Assets FY 2020 · Dec 31, 2019 $1.56M
Eps Diluted FY 2020 · Dec 31, 2020 −$0.09
Eps Diluted FY 2020 · Dec 31, 2019 −$0.04
Eps Diluted FY 2020 · Dec 31, 2018 −$0.06
Eps Basic FY 2020 · Dec 31, 2020 −$0.09
Eps Basic FY 2020 · Dec 31, 2019 −$0.04
Eps Basic FY 2020 · Dec 31, 2018 −$0.06
Net Income FY 2020 · Dec 31, 2020 −$17.07M
Net Income FY 2020 · Dec 31, 2019 −$4.3M
Net Income FY 2020 · Dec 31, 2018 −$3.79M
Gross Profit FY 2020 · Dec 31, 2020 $2.02M
Gross Profit FY 2020 · Dec 31, 2019 $1.21M
Gross Profit FY 2020 · Dec 31, 2018 $674.34K
Cost Of Revenue FY 2020 · Dec 31, 2020 $36.13K
Cost Of Revenue FY 2020 · Dec 31, 2019 $32.9K
Cost Of Revenue FY 2020 · Dec 31, 2018 $0
Revenue FY 2020 · Dec 31, 2020 $3.21M
Revenue FY 2020 · Dec 31, 2019 $2.03M
Revenue FY 2020 · Dec 31, 2018 $1.09M
Cash And Equivalents FY 2020 · Dec 31, 2019 $179.15K
Cash And Equivalents FY 2020 · Dec 31, 2018 $157.67K
Cash And Equivalents restated FY 2020 · Dec 31, 2017 $0